SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Por:
Lopez-Muniz J, Merino L, Gregori J, Duenas E, Oliveira M, Palmer M, Lopez I, Novoa S, Ezquerra M, Cobo S
Publicada:
1 ene 2019
Resumen:
Although the metastasic breast cancer is still an incurable disease, recent advances have increased significantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference.
Filiaciones:
Lopez-Muniz J:
Hosp Virgen Salud, Serv Oncol Med, Avda Barber 30, Toledo 45004, Spain
GEICAM, Madrid, Spain
Merino L:
Univ Seville, Hosp Virgen Macarena, Med Dept, Serv Oncol Med, Seville, Spain
Gregori J:
Fdn Inst Valenciano Oncol, Serv Oncol Med, Valencia, Spain
Duenas E:
Hosp Prov Castellon, Serv Oncol Med, Castellon de La Plana, Spain
Oliveira M:
Vall dHebron Univ Hosp, Barcelona, Spain
Vall dHebron Inst Oncol, Barcelona, Spain
Palmer M:
Corp Sanitaria Parc Tauli, Serv Oncol Med, Barcelona, Spain
Lopez I:
Donostiako Unibertsitate Ospitalea, Hosp Univ Donostia, Serv Oncol Med, Donostia San Sebastian, Spain
Novoa S:
Hosp Univ A Coruna, Serv Oncol Med, La Coruna, Spain
Ezquerra M:
Vall dHebron Univ Hosp, Barcelona, Spain
Vall dHebron Inst Oncol, Barcelona, Spain
Cobo S:
Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Serv Oncol Med,CiberOnc,GEICAM, Madrid, Spain
|